< Back to latest news & events

Articles

UPC on Doctrine of Equivalents

February 2025

Plant-e Knowledge BV & anor v Arkyne Technologies SL UPC_CFI_239/2023 (Brinkman, Granata, Walker & Koke) – 22 November 2024

The Hague Local Division has handed down the first substantive UPC judgment applying the doctrine of equivalents. The Hague LD found that Plant-e’s European Patent No. 2137782 was valid and infringed by equivalence. Where there was no literal infringement of the claims, the Hague LD considered infringement by equivalence.

In assessing whether the variant is equivalent, the Hague LD considered the following questions.  First, does the variation solve essentially the same problem and perform essentially the same function as the patented invention (i.e., technical equivalence)? Second, would extending the scope of protection of the claim to cover the equivalent be proportionate and fair for the patentee? Third, would the skilled person understand from the patent that the scope of the invention is broader than what is claimed literally? Fourth, is the allegedly infringing product novel and inventive over the prior art?

Background

The Patent entitled “Device and Method for Converting Light Energy into Electrical Light” was in force in the Netherlands, Belgium, Luxembourg, Germany, France and Italy.  The invention related to a device and method for converting light energy into electrical energy and/or hydrogen by using a living plant for converting light energy into electrical energy and/or hydrogen.

The Patent claimed a Plant-based-Microbial Fuel Cell (“P-MFC”). An MFC generally comprises a reactor, and the reactor comprises an anode compartment and a cathode compartment. The P-MFC introduced a living plant in the ‘reactor’ that converted (sun)light into nutrients (organic material) by photosynthesis.  The photosynthesis process releases organic compounds into the soil, feeding anodophilic microorganisms surrounding the plant.  When the microorganisms metabolise the compounds, they transfer electrons into their surrounding environment, which are collected and utilised by the anode.  Electrons then travel to the cathode, ultimately creating an electric current.

Plant-e was a Dutch start up spun out of Wageningen University. It developed three products: a small biofuel cell for educational purposes, a biofuel cell for use with a sensor (particularly for use in agriculture) and a biofuel cell with lighting that can be installed in the ground for use in gardens and parks.

Arkyne (a Spanish startup referred to as Bioo in the Decision) offered for sale and sold a small biofuel cell for educational purposes (the ‘Bioo Ed’), a small biofuel cell for use with a sensor (the ‘Bioo Sensor’), a large biofuel cell with lighting that can be buried in the ground for use in gardens and parks (the ‘Bioo Panel’), and a ‘Bioo Bench’ which incorporated three Bioo Panels.

Plant-e Product (Fig.1 of Patent) Bioo Panel

UPC_CFI_239/2023 (Pages 2 and 14)

Plant-e brought infringement proceedings seeking various remedies, including an injunction, an infringement declaration, and destruction of the Bioo infringing products.  Bioo counterclaimed for revocation of the Patent, and argued it was invalid for added matter, and that it lacked novelty, inventive step and sufficient disclosure.

Judgment

Literal infringement

The focus of the infringement case was independent method claim 11, divided into the following integers:

11.1 Method for converting light energy into electrical energy and/or hydrogen

11.2 wherein a feedstock is introduced into a device that comprises a reactor

11.3 where the reactor comprises an anode compartment (2) and a cathode compartment

11.4 and wherein the anode compartment comprises a) an anodophilic microorganism capable of oxidizing an electron donor compound

11.5 and b) a living plant (7) or part thereof, capable of converting light energy by means of photosynthesis into the electron donor compound

11.6 wherein the microorganism lives around the root (8) zone of the plant or part thereof.

As can be seen from the Figure above, the Bioo Panel differed from the claimed invention, as it included two compartments (rather than one) wherein the upper compartment contained the plant and its roots and the lower compartment contained the anode and microorganisms.

The Court held that the Bioo Panel literally applied all features of the claim except for the location of the plant and its roots (together with the microorganisms) in the anode department.  Integer 11.6 was not completely fulfilled in the Bioo Panel, as it could not be established that the roots of the plant were in the anode compartment where anodophilic micro-organisms (mainly) live, as the Bioo Panel separated the plant, roots and microorganisms from the anode compartment.

In light of the above, the Hague LD held that there was no literal infringement of claim 11.

Infringement by equivalence

The UPCA did not provide expressly for a doctrine of equivalents, however, the Hague LD considered that Art. 2 of the Protocol to Art 69 EPC makes clear that equivalence must be considered when assessing the scope of protection.

As set out above, the Hague LD set out a four step test, where each question must be answered in the affirmative to establish infringement by equivalence.  In this action, the Hague LD answered all four questions in the affirmative for the following reasons:

  1. Technical equivalence: The Bioo Panel was designed to achieve the same outcome as claim 11 – it created an MFC independent of externally furnished fuel by introducing a living plant into a system as a constant supplier of organic material to the reactor, creating a P-MFC.
  2. Fair protection for the patentee: The patent claimed a new category of MFCs by introducing a plant into the device/reactor and to obtain electricity from organic material originating from the photosynthesis by that plant and thus from light energy. The Court opined that because it was a new category of MFC, and that Plant-e’s invention was given its own name (P-MFC), “a fairly broad scope of protection is therefore in line with the contribution to the art”.  The Court held that the plant in the Bioo Panel had the same function as in the claim, solved the same problem, and did so in a similar way to the claimed invention. The minor differences (i.e. the extra compartment and location of the roots/microorganisms) did not affect the function of the plant and was therefore deemed to be equivalent.
  3. Legal certainty for third parties: Interestingly, the Court held that this requirement is met “if the skilled person[1] understands that the patent claim leaves room for equivalents because the teaching of the patent is (clearly) broader than the wording of the claim” and there is no good reason to limit the scope of protection.
  4. Bioo Panel inventive and novel (‘reverse Gillette/Formstein defence’): the parties agreed that the Bioo Panel would have been novel and inventive over the prior art at the priority date.

Therefore, the Hague LD held that the Bioo Panel infringed (by equivalence) claim 11 of the Patent.

Conclusion

As the first substantive judgment applying a doctrine of equivalents, this is an important step for the UPC.  The Hague LD has set out a proposed test for considering equivalents which is similar to the Dutch patents court’s approach.  As this is an area of divergence in the application of the EPC as between the national patents courts, parties will be watching this development keenly.  It is not a given that other UPC Divisions will adopt the same approach of The Hague LD, or if the Court of Appeal will agree or adopt a different test.

Arkyne/Bioo had not filed an appeal to the UPC Court of Appeal before the deadline.  Therefore, a LD test for the doctrine of equivalents remains the only guidance we have on how the UPC will apply the test.

[1] The Hague LD held that the skilled team for the purposes of the Patent had a scientific background to PhD level in biochemistry, electrochemistry and possibly microbiology or environmental engineering with 3-4 years practical experience of working in the field of MFC.


This article was written by HGF Partner and Head of Law Rachel Fetches and IP Solicitor Sian Hope

Latest updates

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Personal names as 'brands' in the world of fashion

Episode 1 Personal names as ‘brands’ in the world of fashion    

Read article

Colour in fashion and the difficulties of protecting it

Episode 2 Colour in fashion and the difficulties of protecting it  

Read article

Trade marks which are fashion products, and fashion products which are trade marks

Episode 3 Trade marks which are fashion products, and fashion products which are trade marks

Read article

Zombie Fashion Brands

Episode 4 Zombie Fashion Brands  

Read article

Trade mark rights protecting fashion designs

Episode 5 Trade mark rights protecting fashion designs

Read article